Company Overview of AbNovo, Inc.
AbNovo, Inc. develops antibody treatments for viral infections. The company develops monoclonal antibodies to treat chronic viral infections through modulation of the immune system. The company is based in Vancouver, Canada. AbNovo, Inc. operates as a subsidiary of Immune Network Ltd.
202-1128 West Boadway
Vancouver, BC V6H 1G5
Key Executives for AbNovo, Inc.
Similar Private Companies By Industry
|1113131 B.C. Ltd.||Americas|
|1127466 B.C. Ltd.||Americas|
|1600978 Ontario Inc.||Americas|
|48North Cannabis Corporation||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
To contact AbNovo, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.